TECH - Bio-Techne Corp

NYSE * Healthcare * Biotechnology

$66.36

$-0.20 (-0.30%)

About Bio-Techne Corp

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

TECH Key Statistics

Market Cap

$10.37B

P/E Ratio

135.84

P/B Ratio

5.21

EPS

$0.49

Dividend Yield

0.00%

Revenue Growth

-0.0%

Profit Margin

0.1%

Employees

3,100

How TECH Compares to Peers

TECH trades at a premium valuation vs peers (highest P/E)
TECH is the smallest among peers, which may offer higher growth potential

P/E Rank

#5

of 5

Margin Rank

#5

of 5

Growth Rank

#5

of 5

Size Rank

#5

of 5

CompanyMarket CapP/ERev GrowthMarginCompare
TECH(This stock)$10.37B135.8-0.0%0.1%-
AMGNAmgen Inc$175.30B25.20.1%0.2%vs AMGN
GILDGilead Sciences$152.12B19.00.0%0.3%vs GILD
VRTXVertex Pharmaceuticals$118.09B32.40.1%0.3%vs VRTX
BIIBBiogen Inc$27.23B16.90.0%0.2%vs BIIB

Bio-Techne Corp Company Information

Headquarters
614 McKinley Place N.E., Minneapolis, MN, United States, 55413, undefined
Website
www.bio-techne.com
Sector
Healthcare
Industry
Biotechnology
Data Updated:

TECH Lician Score

10% confidence
5.0/10
Neutral

TECH has a Lician Score of 5/10 (Average). Areas of concern: Growth.

value

5.0

growth

3.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates TECHacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

TECH Financial Snowflake

5-axis analysis across key investment dimensions

4.6/10

Neutral

35810Value5.0Growth3.0Quality5.0Momentum5.0Safety5.04.6/10
5.0

Value

3.0

Growth

5.0

Quality

5.0

Momentum

5.0

Safety

Upcoming Events for TECH